Surrogate decision-making and related issues

Alzheimer Disease and Associated Disorders

Volumn 17, Issue SUPPL. 1, 2003, Pages

  Beck, Cornelia ^a,c   Shue, Valorie ^b  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^b UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^c NONE   (United States)

Author keywords

Alzheimer disease; Decision making; Dementia; Research; Surrogate

Indexed keywords

ALZHEIMER DISEASE; AUTHORITY; CLINICAL RESEARCH; COMPETENCE; CONFERENCE PAPER; CUSTODY; DECISION MAKING; HUMAN; INFORMED CONSENT; LAW; LIVING WILL; MEDICAL ETHICS; PRIORITY JOURNAL; RESPONSIBILITY;

EID: 0038647788     PISSN: 08930341     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002093-200304001-00003     Document Type: Conference Paper

References (15)

1. Alzheimer's Association. Ethical Issues in Dementia Research. Chicago: Alzheimer's Association, 1997.
2. Berg JW, Appelbaum PS, Lidz CW, Parker LS. The independent evolution of informed consent to research. Informed consent. New York: Oxford University Press, 2001.
3. Berg JW. Legal and ethical complexities of consent with cognitively impaired research subjects: Proposed guidelines. J Law Med Ethics 1996;24:18-35.
4. Missouri State Legislators. Experimental treatment, tests, and drugs, consent to administer by third party. 431, 431.064. 9-28-0200.
5. Sachs GA. Informed consent for research on human subjects with dementia. J Am Geriatr Soc 1998;46:1308-10.
6. The Office of Human Subjects Research, National Institutes of Health. Research involving cognitively impaired subjects: a review of some ethical considerations. On-line at 2000.http://ohsr.od.nih.gov/info/ginfo_7.php3
7. Hopp FP. Preferences for surrogate decision makers, informal communication, and advance directives among community-dwelling elders: results from a national study. Gerontologist 2000;40:449-57.
8. National Bioethics Advisory Commission. Research involving persons with mental disorders that may affect decision making capacity. Vol. I. 1-88. 1998. Rockville, MD: National Bioethics Advisory Commission. 1998:1-88.
9. Resau LS. Obtaining informed consent in Alzheimer's research. J Neurosci Nurs 1995;27:57-60.
10. High DM, Whitehouse PJ, Post SG, Berg L. Guidelines for addressing ethical and legal issues in Alzheimer disease research: a position paper. Alzheimer Dis Assoc Disord 1994;8(suppl 4):66-74.
11. Melnick VL, Dubler NN, Weisbard A, Butler RN. Clinical research in senile dementia of the Alzheimer type: suggested guidelines addressing the ethical and legal issues. J Am Geriatr Soc 1984;32:531-6.
12. Brodaty H, Dresser R, Eisner M, et al. Alzheimer's disease international and international working group for harmonization of dementia drug guidelines for research involving human subjects with dementia. Alzheimer Dis Assoc Disord 1999;13:71-9.
13. Baskin SA, Morris J, Ahronheim JC, Meier DE, Morrison RS. Barriers to obtaining consent in dementia research: implications for surrogate decision-making. J Am Geriatr Soc 1998;46:287-90.
14. Markson L, Snyder L, Steel RK. Cognitively impaired subjects. Ann Intern Med 1989;111:843-8.
15. Sugarman J, Cain C, Wallace R, Welsh-Bohmer KA. How proxies make decisions about research for patients with Alzheimer's disease. J Am Geriatr Soc 2001;49:1110-9.